DCT

3:18-cv-03244

Boehringer Ingelheim Pharma Inc v. Fresenius Kabi USA LLC

General
Filed
03/07/18
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (07/07/20)
Patent Owner
NPE (W)
Judge
Period
PO Win Rate
--
61%